These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10962030)

  • 1. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.
    Halmos G; Schally AV; Varga JL; Plonowski A; Rekasi Z; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10555-60. PubMed ID: 10962030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Armatis P; Groot K; Czompoly T
    Endocrinology; 2000 Jun; 141(6):2120-8. PubMed ID: 10830299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
    Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.
    Kiaris H; Schally AV; Busto R; Halmos G; Artavanis-Tsakonas S; Varga JL
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):196-200. PubMed ID: 11773624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of growth hormone-releasing hormone (GHRH) binding to cloned porcine GHRH receptor.
    Hassan HA; Hsiung HM; Zhang XY; Smith DP; Smiley DL; Heiman ML
    Peptides; 1995; 16(8):1469-73. PubMed ID: 8745060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep loss alters hypothalamic growth hormone-releasing hormone receptors in rats.
    Gardi J; Taishi P; Speth R; Obal F; Krueger JM
    Neurosci Lett; 2002 Aug; 329(1):69-72. PubMed ID: 12161265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor.
    Veyrat-Durebex C; Pomerleau L; Langlois D; Gaudreau P
    J Cell Physiol; 2005 May; 203(2):335-44. PubMed ID: 15499571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers.
    Plonowski A; Schally AV; Busto R; Krupa M; Varga JL; Halmos G
    Peptides; 2002 Jun; 23(6):1127-33. PubMed ID: 12126741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in GHRH binding and GHRH receptor mRNA in the pituitary of adult dw/dw rats.
    Gardi J; Speth RC; Taishi P; Kacsóh B; Obál F; Krueger JM
    Peptides; 2002 Aug; 23(8):1497-502. PubMed ID: 12182953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.
    Rekasi Z; Czompoly T; Schally AV; Halmos G
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10561-6. PubMed ID: 10962031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel.
    Hohla F; Schally AV; Szepeshazi K; Varga JL; Buchholz S; Köster F; Heinrich E; Halmos G; Rick FG; Kannadka C; Datz C; Kanashiro CA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14513-8. PubMed ID: 16983095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.
    Busto R; Schally AV; Varga JL; Garcia-Fernandez MO; Groot K; Armatis P; Szepeshazi K
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11866-71. PubMed ID: 12186980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
    Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
    Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches.
    Szabo Z; Juhasz E; Schally AV; Dezso B; Huga S; Hernadi Z; Halmos G; Kiss C
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.
    Varga JL; Schally AV; Horvath JE; Kovacs M; Halmos G; Groot K; Toller GL; Rekasi Z; Zarandi M
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1708-13. PubMed ID: 14755056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
    Kovacs M; Schally AV; Lee EJ; Busto R; Armatis P; Groot K; Varga JL
    J Endocrinol; 2002 Nov; 175(2):425-34. PubMed ID: 12429040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.